Weight loss / metabolic (GLP-1)

Semaglutide

Ozempic, Wegovy

FDA-approved, strong human data
Based on expert consensus from publicly available videos plus public FDA/regulatory status — not medical advice. Peptides are prescription territory; consult a physician before using anything here.

The Verdict

The most-established GLP-1 — real trials, real weight loss, and cardiovascular benefit. The catch experts stress is muscle loss: pair it with protein and resistance training.

The Evidence

FDA / Legal Status

FDA-approved (type 2 diabetes and obesity)

Human Evidence

Large randomized trials (STEP, SELECT) — ~15% average weight loss plus cardiovascular benefit

Sport / Doping

Not a typical doping agent; prescription drug

Safety Flags

  • Significant lean-muscle loss without protein + resistance training (Attia calls the rate 'alarming')
  • GI side effects (nausea, vomiting) during titration; weight regain common if stopped

Who Covers It

Peter Attia
Peter Attia
Andrew Huberman
Andrew Huberman
Mark Hyman
Mark Hyman
Rhonda Patrick
Rhonda Patrick

Other experts in the panel had no substantive coverage of this peptide — we don't guess their position.

Want the deep dive on Semaglutide?

This grade is free. Pro unlocks chat with the full expert dataset — ask about dosing, stacks, sourcing, and the exact citations behind every claim.

Cancel anytime

Go Deeper